*Health experts say research findings have shown the headache remedy can reduce the risk of death from COVID-19

Isola Moses | 绿帽献妻
Aspirin has been promoted for a variety of health benefits over the years, some of them questionable.

Now, researchers have opined their findings indicated that the headache remedy can reduce the risk of death from COVID-19.

It was learnt the researchers at George Washington University, in the United States (US) noted that patients in the hospital with moderate COVID-19, who were given aspirin early on in their treatment had a lower risk of dying compared to patients who were not given aspirin.

Lead researcher Jonathon Chow said: 鈥淲e continue to find that aspirin use is associated with improved outcomes and lower rates of death in hospitalised patients.

鈥淲hat’s more, it鈥檚 low cost and readily available, which is important in parts of the world where more expensive therapeutics might not be as accessible.”

COVID-19 researchers under personal attacks

In a related development, a study discovered COVID-19 researchers faced harassment.

Report says the COVID-19 pandemic may be the most politically-charged disease in modern times, with raging controversy over vaccinations, treatments, and mitigation tactics.

The fresh study found that several COVID-19 researchers have come under personal attack over the last two years.

The study, published in the journal, Science, included responses from 510 researchers who have published data about the virus.

Nearly 40 percent of them reported that their work had drawn harassment.

Scientists increased their chances of drawing attacks if their work resulted in arguments against the use of the drug ivermectin and other unapproved treatments. Eighteen of the scientists said they had received death threats in this regard.[do_widgetid=heatoer_sss_sharing-2]